CDC shakeup, Novo bets on srRNA, and early GBM data impress. This Week in Biotech is out now.

Susan Monarez is out at the CDC after just weeks, Novo inks a $550M srRNA deal, and ImmunityBio posts striking glioblastoma results. Plus: new COVID vaccine rules, Gilead’s long-acting PrEP approval, and more.